Accuracy of 68Ga-Pentixafor PET/CT for Subtypting Diagnosis in Patients With Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

To evaluate the accuracy of 68Ga-Pentixafor PET-CT in the classification diagnosis of primary aldosteronism concurrent with autonomous cortisol secretion patient, using AVS and/or postoperative remission as the reference standard for classification diagnosis.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Getting the written informed consent

• The clear diagnosis of primary aldosteronism;

• Combined with autonomous cortisol secretion, cortisol after 1mg dexamethasone suppression test (DST) ≥50 nmol/l;

• Patients who are willing to undergo surgery;

• Adrenal CT or MRI scan of the adrenal glands with nodule (≥1cm).

Locations
Other Locations
China
The First Affilated Hospital of Chongqing Medical University
RECRUITING
Chongqing
Contact Information
Primary
Qi fu Li, PhD
liqifu@yeah.net
86-89011552
Time Frame
Start Date: 2024-08-12
Estimated Completion Date: 2027-08-12
Participants
Target number of participants: 97
Related Therapeutic Areas
Sponsors
Collaborators: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital of Zhengzhou University, The Affiliated Hospital Of Southwest Medical University, The Third Xiangya Hospital of Central South University
Leads: Qifu Li

This content was sourced from clinicaltrials.gov